Intellectual Property India Publishes Patent Application for 'Pharmaceutical Composition Of Folic Acid Conjugated Docetaxel/Erlotinib-Loaded Solid Lipid Nanoparticles' Filed by Indian Institute Of Technology (Banaras Hindu University)

MUMBAI, India, Aug. 29 -- Intellectual Property India has published a patent application (202411010322 A) filed by Indian Institute Of Technology (Banaras Hindu University), Varanasi, Uttar Pradesh, on Feb. 14, 2024, for 'pharmaceutical composition of folic acid conjugated docetaxel/erlotinib-loaded solid lipid nanoparticles.'

Inventor(s) include Agrawal, Ashish Kumar; Chaudhuri, Aiswarya; Dulla, Naveen Kumar; and Kumar, Dinesh.

The application for the patent was published on Aug. 29, under issue no. 35/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to a pharmaceutical composition comprising: a) a folic acid conjugated docetaxel solid lipid nanoparticle; and b) a folic acid conjugated erlotinib solid lipid nanoparticle, wherein the folic acid conjugated docetaxel solid lipid nanoparticle and the folic acid conjugated erlotinib solid lipid nanoparticle are present in a ratio in the range of 1-3 : 1-4."

Disclaimer: Curated by HT Syndication.